Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: there isn’t a stable, public list — after the FDA’s warnings most of the large telehealth companies stopped offering compounded GLP‑1 products and now prescribe FDA‑approved GLP‑1 drugs instead. Only small/boutique telehealth + compounding‑pharmacy partnerships (which change rapidly and vary by state) still advertise compounded GLP‑1s.

What changed and why it matters

• In 2023–2024 the FDA publicly discouraged use of compounded versions of GLP‑1s because they can be unsafe, lack standard quality controls, and may be illegal when an approved product exists. Many mainstream telehealth companies stopped compounding or referring to compounding pharmacies as a result.
• That means most reputable telehealth platforms now prescribe the FDA‑approved drugs (Wegovy, Ozempic, Rybelsus, Mounjaro, Zepbound) instead of compounded semaglutide/tirzepatide.

Where people still find compounded GLP‑1s (what to watch for)

• Small telehealth outfits that partner with independent compounding pharmacies; availability depends on state pharmacy law and the compounding pharmacy’s policies.
• Independent compounding pharmacies (PCAB‑accredited or PCCA members) that will fill prescriptions if you have a valid prescription from a licensed prescriber. Examples of large compounding pharmacies that historically compounded peptides (availability may have changed): Empower Pharmacy, Wedgewood Pharmacy, Belmar Pharmacy — but you must confirm current practices with each pharmacy.
• NOTE: I can’t verify whether any specific provider is currently offering compounded GLP‑1s in your state; offers have been pulled quickly after FDA action and vary by location.

Safer alternatives I recommend

• Use a telehealth provider that prescribes FDA‑approved GLP‑1 medications and provides follow‑up care. Major telehealth companies that commonly manage GLP‑1 therapy (using approved drugs) include Hims & Hers, Ro (Roman), PlushCare and Teladoc — they’ll help with prescriptions for branded products and monitoring.
• If you’re considering a compounded product, insist on:
  • PCAB accreditation or clear third‑party sterility/quality testing from the compounding pharmacy,
  • Written disclosure of where the active drug was sourced and results of any testing,
  • Clear physician oversight and documented informed‑consent discussing risks,
  • Compliance with your state pharmacy board rules.

If you want, I can:

• Check a specific telehealth company or compounding pharmacy for up‑to‑date status (tell me the company name and your state), or
• Help you compare an FDA‑approved GLP‑1 program from telehealth providers (costs, follow‑up, prescribing policies).